RNAi-based therapies for Huntington’s disease: delivery challenges and opportunities

about

Stem cells for cell replacement therapy: a therapeutic strategy for HD?

P2860

Q35250495-18B49BD9-5963-435E-8873-5D92761DD182

P2860

RNAi-based therapies for Huntington’s disease: delivery challenges and opportunities

Item

http://www.wikidata.org/entity/Q56192358

description

article

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована у вересні 2012

@uk

ലേഖനം

@ml

name

RNAi-based therapies for Huntington’s disease: delivery challenges and opportunities

@en

RNAi-based therapies for Huntington’s disease: delivery challenges and opportunities

@nl

type

Item

label

RNAi-based therapies for Huntington’s disease: delivery challenges and opportunities

@en

RNAi-based therapies for Huntington’s disease: delivery challenges and opportunities

@nl

prefLabel

RNAi-based therapies for Huntington’s disease: delivery challenges and opportunities

@en

RNAi-based therapies for Huntington’s disease: delivery challenges and opportunities

@nl

P1476

RNAi-based therapies for Huntington’s disease: delivery challenges and opportunities

@en

P2093

Nandita G Das

http://www.w3.org/2001/XMLSchema#string

Neelima Mantha

http://www.w3.org/2001/XMLSchema#string

Sudip K Das

http://www.w3.org/2001/XMLSchema#string

P2860

Selective gene silencing by viral delivery of short hairpin RNA

Huntingtin interacting protein 1 induces apoptosis via a novel caspase-dependent death effector domain

Sequence-specific potent induction of IFN-alpha by short interfering RNA in plasmacytoid dendritic cells through TLR7

Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs

Huntingtin and huntingtin-associated protein 1 influence neuronal calcium signaling mediated by inositol-(1,4,5) triphosphate receptor type 1

HIP-I: a huntingtin interacting protein isolated by the yeast two-hybrid system

Cancer siRNA therapy by tumor selective delivery with ligand-targeted sterically stabilized nanoparticle

RNA interference: biology, mechanism, and applications

Preclinical safety of RNAi-mediated HTT suppression in the rhesus macaque as a potential therapy for Huntington's disease

The promises and pitfalls of RNA-interference-based therapeutics

P304

1061-1076

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4155/TDE.12.80

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2012-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

232085191

http://www.w3.org/2001/XMLSchema#string

P921

Huntington disease

RNAi-based therapies for Huntington’s disease: delivery challenges and opportunities

about

P2860

P2860

RNAi-based therapies for Huntington’s disease: delivery challenges and opportunities

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P921